Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Kjell Nustad

141 publications found

Original articles

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N (2017)
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L (2015)
HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank
Int J Gynecol Cancer, 25 (9), 1608-15
DOI 10.1097/IGC.0000000000000532, PubMed 26501436

Bolstad N, Warren DJ, Nustad K (2013)
Heterophilic antibody interference in immunometric assays
Best Pract Res Clin Endocrinol Metab, 27 (5), 647-61
DOI 10.1016/j.beem.2013.05.011, PubMed 24094636

Bolstad N, Øijordsbakken M, Nustad K, Bjerner J (2011)
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Tumour Biol, 33 (1), 141-8
DOI 10.1007/s13277-011-0256-4, PubMed 22105734

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2011)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Clin Chem Lab Med, 49 (12), 2001-6
DOI 10.1515/CCLM.2011.702, PubMed 21899496

Warsame AA, Aasheim HC, Nustad K, Trøen G, Tierens A, Wang V, Randen U, Dong HP, Heim S, Brech A, Delabie J (2011)
Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity
Blood, 118 (12), 3331-9
DOI 10.1182/blood-2011-03-341651, PubMed 21725051

Holen HL, Nustad K, Aasheim HC (2010)
Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration
J Leukoc Biol, 87 (6), 1059-68
DOI 10.1189/jlb.0709497, PubMed 20160140

Harvey RA, Mitchell HD, Stenman UH, Blankenstein MA, Nustad K, Stieber P, Stewart W, Savage PM, Seckl MJ, Braunstein GD (2010)
Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors
J Reprod Med, 55 (7-8), 285-95
PubMed 20795340

Lund H, Torsetnes SB, Paus E, Nustad K, Reubsaet L, Halvorsen TG (2009)
Exploring the complementary selectivity of immunocapture and MS detection for the differentiation between hCG isoforms in clinically relevant samples
J Proteome Res, 8 (11), 5241-52
DOI 10.1021/pr900580n, PubMed 19719329

Nustad K, Nilsson O, Majnesjö K, Murakami A, Sugino N, Warren DJ, Kato H (2009)
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the second TD-10 workshop
Tumour Biol, 30 (1), 26-36
DOI 10.1159/000199448, PubMed 19194112

Warren DJ, Nustad K, Beard JB, O'Brien TJ (2009)
Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop
Tumour Biol, 30 (2), 51-60
DOI 10.1159/000209988, PubMed 19321947

Nordlund MS, Warren DJ, Nustad K, Bjerner J, Paus E (2008)
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide
Clin Chem, 54 (5), 919-22
DOI 10.1373/clinchem.2007.101436, PubMed 18443179

Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E (2008)
Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
Tumour Biol, 29 (3), 204-10
DOI 10.1159/000148188, PubMed 18667845

Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K (2008)
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study
Scand J Clin Lab Invest, 68 (8), 703-13
DOI 10.1080/00365510802126836, PubMed 18609108

Bjerner J, Olsen KH, Børmer OP, Nustad K (2005)
Human heterophilic antibodies display specificity for murine IgG subclasses
Clin Biochem, 38 (5), 465-72
DOI 10.1016/j.clinbiochem.2005.02.008, PubMed 15820778

Warren DJ, Bjerner J, Paus E, Børmer OP, Nustad K (2005)
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies
Clin Chem, 51 (5), 830-8
DOI 10.1373/clinchem.2004.046979, PubMed 15718486

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A (2004)
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study
Br J Cancer, 91 (10), 1829-34
DOI 10.1038/sj.bjc.6602199, PubMed 15477862

Bjerner J, Olsen KH, Børmer OP, Nustad K (2004)
Testing and validating a homogeneous immunometric assay for interference
Clin Chem Lab Med, 42 (2), 208-14
DOI 10.1515/CCLM.2004.038, PubMed 15061363

Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E (2004)
Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
Tumour Biol, 25 (1-2), 31-40
DOI 10.1159/000077721, PubMed 15192310

Nustad K, Dowell BL, Davis GJ, Stewart K, Nilsson O, Röijer E, Suminami Y, Nawata S, Cataltepe S, Silverman GA, Kato H, de Bruijn HW (2004)
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the TD-10 Workshop
Tumour Biol, 25 (1-2), 69-90
DOI 10.1159/000077726, PubMed 15192315

Bjerner J, Lebedin Y, Bellanger L, Kuroki M, Shively JE, Varaas T, Nustad K, Hammarström S, Børmer OP (2002)
Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop
Tumour Biol, 23 (4), 249-62
DOI 10.1159/000067255, PubMed 12499780

Nustad K, Lebedin Y, Lloyd KO, Shigemasa K, de Bruijn HW, Jansson B, Nilsson O, Olsen KH, O'Brien TJ, ISOBM TD-1 Workshop (2002)
Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop
Tumour Biol, 23 (5), 303-14
DOI 10.1159/000068570, PubMed 12595747

Bjerner J, Nustad K, Norum LF, Olsen KH, Børmer OP (2002)
Immunometric assay interference: incidence and prevention
Clin Chem, 48 (4), 613-21
PubMed 11901059

Bjerner J, Norum LF, Nilsson O, Nustad K (2002)
MUC1 serum assays in breast cancer: tumor specificities and reference levels
Tumour Biol, 23 (6), 315-23
DOI 10.1159/000069790, PubMed 12677089

Magnusson P, Arlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL (2002)
Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop
Tumour Biol, 23 (4), 228-48
DOI 10.1159/000067254, PubMed 12499779

Rye PD, Nustad K (2001)
Immunomagnetic DNA aptamer assay
Biotechniques, 30 (2), 290-2, 294-5
DOI 10.2144/01302st01, PubMed 11233597

Hovig E, Rye PD, Warren DJ, Nustad K (2001)
CA 125: the end of the beginning
Tumour Biol, 22 (6), 345-7
DOI 10.1159/000050637, PubMed 11786728

Norum LF, Nilsson O, Nustad K (2001)
Automated immunofluorometric assay for MUC1
Tumour Biol, 22 (3), 169-75
DOI 10.1159/000050612, PubMed 11275795

Norum LF, Sauren AM, Rye PD, Nustad K (2001)
New immunoassays for MUC1 in breast cancer
Tumour Biol, 22 (4), 216-22
DOI 10.1159/000050619, PubMed 11399946

Norum LF, Erikstein B, Nustad K (2001)
Elevated CA125 in breast cancer--A sign of advanced disease
Tumour Biol, 22 (4), 223-8
DOI 10.1159/000050620, PubMed 11399947

Hogdall EV, Høgdall CK, Tingulstad S, Hagen B, Nustad K, Xu FJ, Bast RC, Jacobs IJ (2000)
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass
Int J Cancer, 89 (6), 519-23
DOI 10.1002/1097-0215(20001120)89:6<519::AID-IJC9>3.0.CO;2-#, PubMed 11102897

Paulsen T, Marth C, Kaern J, Nustad K, Kristensen GB, Tropé C (2000)
Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
Gynecol Oncol, 76 (3), 326-30
DOI 10.1006/gyno.1999.5699, PubMed 10684705

Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M (1999)
The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals
Obstet Gynecol, 93 (3), 448-52
DOI 10.1097/00006250-199903000-00028, PubMed 10074998

Paus E, Nustad K, Børmer OP (1999)
Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen
Tumour Biol, 20 Suppl 1, 52-69
DOI 10.1159/000056531, PubMed 10628410

Rye PD, Bovin NV, Vlasova EV, Molodyk AA, Baryshnikov A, Kreutz FT, Garinther WI, Schultes BC, Noujaim AA, Madiyalakan R, Magnani J, Nilsson O, Nilsson K, Nustad K, Norum L, Bell H, Cao Y, Suresh MR, Very DL, Freeman JV, Yeung KK, Hilgers J (1998)
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997
Tumour Biol, 19 (5), 390-420
DOI 10.1159/000030032, PubMed 9701730

Norum LF, Varaas T, Kierulf B, Nustad K (1998)
Carcinoma-associated MUC1 detected by immunoradiometric assays
Tumour Biol, 19 Suppl 1, 134-46
DOI 10.1159/000056515, PubMed 9422099

Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MFA, Snijdewint FGM, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilkens J et al. (1998)
Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin - San Diego, Calif., November 17-23, 1996
Tumor Biol., 19 1, 1-20
DOI 10.1159/000056500

Nustad K, Onsrud M, Jansson B, Warren D (1998)
CA 125--epitopes and molecular size
Int J Biol Markers, 13 (4), 196-9
DOI 10.1177/172460089801300404, PubMed 10228900

Nustad K, Paus E, Kierulf B, Børmer OP (1998)
Specificity and affinity of 30 monoclonal antibodies against alpha-fetoprotein
Tumour Biol, 19 (4), 293-300
DOI 10.1159/000030021, PubMed 9679741

Larsen RH, Varaas T, Hoff P, Vergote IB, Alstad J, DeVos LN, Nustad K (1996)
Evaluation of At-211-labelled monodisperse polymer particles in vivo: Comparison of different specific activities
J. Label. Compd. Radiopharm., 38 (9), 775-784
DOI 10.1002/(SICI)1099-1344(199609)38:9<775::AID-JLCR896>3.0.CO;2-U

Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K (1996)
Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses
Br J Obstet Gynaecol, 103 (8), 826-31
DOI 10.1111/j.1471-0528.1996.tb09882.x, PubMed 8760716

Ugelstad J, Stenstad P, Kilaas L, Prestvik WS, Rian A, Nustad K, Herje R, Berge A (1996)
Biochemical and biomedical application of monodisperse polymer particles
Macromol. Symp., 101, 491-500
DOI 10.1002/masy.19961010155

Onsrud M, Shabana A, Austgulen R, Nustad K (1995)
Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer
Gynecol Oncol, 57 (2), 183-7
DOI 10.1006/gyno.1995.1122, PubMed 7729731

Larsen RH, Hoff P, Vergote IB, Bruland OS, Aas M, De Vos L, Nustad K (1995)
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
Gynecol Oncol, 57 (1), 9-15
DOI 10.1006/gyno.1995.1093, PubMed 7705707

Hagen B, Tingulstad S, Onsrud M, Moen M, Kiserud T, Eik-Nes S, Halvorsen T, Nustad K (1995)
[Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status]
Tidsskr Nor Laegeforen, 115 (7), 820-2
PubMed 7701488

Frengen J, Nustad K, Schmid R, Lindmo T (1995)
A sequential binding assay with a working range extending beyond seven orders of magnitude
J Immunol Methods, 178 (1), 131-40
DOI 10.1016/0022-1759(94)00251-q, PubMed 7530267

Frengen J, Lindmo T, Paus E, Schmid R, Nustad K (1995)
Dual analyte assay based on particle types of different size measured by flow cytometry
J Immunol Methods, 178 (1), 141-51
DOI 10.1016/0022-1759(94)00252-r, PubMed 7530268

Børmer OP, Paus E, Nustad K, Theodorsen L (1994)
[Tumor marker analyses--valuable tools if used correctly]
Tidsskr Nor Laegeforen, 114 (28), 3317-20
PubMed 7809890

Frengen J, Kierulf B, Schmid R, Lindmo T, Nustad K (1994)
Demonstration and minimization of serum interference in flow cytometric two-site immunoassays
Clin Chem, 40 (3), 420-5
PubMed 7510591

LARSEN RH, HASSFJELL SP, HOFF P, ALSTAD J, OLSEN E, VERGOTE IB, DEVOS LN, BJORGUM J, NUSTAD K (1993)
AT-211-LABELING OF POLYMER PARTICLES FOR RADIOTHERAPY - SYNTHESIS, PURIFICATION AND STABILITY
J. Label. Compd. Radiopharm., 33 (10), 977-986
DOI 10.1002/jlcr.2580331012

Ottestad L, Andersen TI, Nesland JM, Skrede M, Tveit KM, Nustad K, Børresen AL (1993)
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis
Acta Oncol, 32 (3), 289-94
DOI 10.3109/02841869309093597, PubMed 8100712

Fjeld J, Brorson B, Martinussen GK, Benestad H, Nustad K (1993)
Immunoconjugate stability in vivo measured by label release from 125I or 99mTc-antibody coated cells kept in intraperitoneal diffusion chambers in mice
Acta Oncol, 32 (7-8), 873-6
DOI 10.3109/02841869309096149, PubMed 8305239

ANDERSSON TR, SANDSET PM, NUSTAD K, ABILDGAARD U (1993)
EVIDENCE THAT HEPARIN COFACTOR-II PARTICIPATES IN THE CONTROL OF DISSEMINATED INTRAVASCULAR COAGULATION
INT CONGR SER, 1044, 125-128

Vergote I, Larsen RH, de Vos L, Nesland JM, Bruland O, Bjørgum J, Alstad J, Tropé C, Nustad K (1992)
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model
Gynecol Oncol, 47 (3), 366-72
DOI 10.1016/0090-8258(92)90141-5, PubMed 1473751

Vergote I, Larsen RH, De Vos L, Winderen M, Ellingsen T, Bjørgum J, Hoff P, Aas M, Tropé C, Nustad K (1992)
Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice
Gynecol Oncol, 47 (3), 358-65
DOI 10.1016/0090-8258(92)90140-e, PubMed 1473750

Fjeld JG, Benestad HB, Stigbrand T, Nustad K (1992)
In vivo measurement of the association constant of a radio-labelled monoclonal antibody in experimental immunotargeting
Br J Cancer, 66 (1), 74-8
DOI 10.1038/bjc.1992.219, PubMed 1637680

Andersson TR, Sie P, Pelzer H, Aamodt LM, Nustad K, Abildgaard U (1992)
Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation
Thromb Res, 66 (5), 591-8
DOI 10.1016/0049-3848(92)90313-y, PubMed 1523613

Vergote I, De Vos L, Fjeld J, Nesland J, Kierulf B, Michaelsen T, Nustad K (1992)
B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production
Hybridoma, 11 (3), 323-31
DOI 10.1089/hyb.1992.11.323, PubMed 1500068

Fjeld JG, Michaelsen TE, Nustad K (1992)
The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens
Eur J Nucl Med, 19 (6), 402-8
DOI 10.1007/BF00177366, PubMed 1618231

Vergote IB, Abeler VM, Børmer OP, Stigbrand T, Tropé C, Nustad K (1992)
CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma
Tumour Biol, 13 (3), 168-74
DOI 10.1159/000217761, PubMed 1626181

Fjeld JG, Vergote I, De Vos L, Nustad K (1992)
Radio-immunotargeting in experimental animal models of intraperitoneal cancer
Acta Obstet Gynecol Scand Suppl, 155, 105-11
DOI 10.1111/j.1600-0412.1992.tb00015.x, PubMed 1502887

FJELD JG, MICHAELSEN TE, BENESTAD HB, NUSTAD K (1991)
THE EFFECT OF THE BIODISTRIBUTION DIFFERENCES BETWEEN IGG, F(AB')2 AND FAB' ON THEIR IMMUNOTARGETING POTENTIAL FOR HUMAN TUMOR-CELLS IN IMMUNOCOMPETENT MICE
Antib. Immunoconjug. Radiopharm., 4 (4), 443-451

Børmer OP, Paus E, Nustad K (1991)
Tumour markers as seen from the clinical laboratory: physiological, biochemical, and analytical aspects
Scand J Clin Lab Invest Suppl, 206, 12-20
DOI 10.3109/00365519109107721, PubMed 1947756

Liabakk NB, Nustad K, Espevik T (1990)
A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles
J Immunol Methods, 134 (2), 253-9
DOI 10.1016/0022-1759(90)90387-b, PubMed 2254670

Nygren PA, Ljungquist C, Trømborg H, Nustad K, Uhlén M (1990)
Species-dependent binding of serum albumins to the streptococcal receptor protein G
Eur J Biochem, 193 (1), 143-8
DOI 10.1111/j.1432-1033.1990.tb19315.x, PubMed 2171929

Fjeld JG, Bruland OS, Benestad HB, Schjerven L, Stigbrand T, Nustad K (1990)
Radioimmunotargeting of human tumour cells in immunocompetent animals
Br J Cancer, 62 (4), 573-8
DOI 10.1038/bjc.1990.332, PubMed 2223574

Börmer OP, Nustad K (1990)
Selection of monoclonal antibodies for use in an immunometric assay for carcinoembryonic antigen
J Immunol Methods, 127 (2), 171-8
DOI 10.1016/0022-1759(90)90066-5, PubMed 1690245

Lindmo T, Børmer O, Ugelstad J, Nustad K (1990)
Immunometric assay by flow cytometry using mixtures of two particle types of different affinity
J Immunol Methods, 126 (2), 183-9
DOI 10.1016/0022-1759(90)90149-p, PubMed 2303729

Nustad K (1990)
Application of monosized, polymer particles in medicine
Scand J Clin Lab Invest Suppl, 202, 25-6
PubMed 2075438

Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB (1990)
Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation
Eur J Immunol, 20 (1), 201-6
DOI 10.1002/eji.1830200129, PubMed 1689662

NUSTAD K (1990)
APPLICATION OF MONOSIZED, POLYMER PARTICLES IN MEDICINE
Scand. J. Clin. Lab. Invest., 50 202, 25-26

Paus E, Nustad K (1989)
Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles
Clin Chem, 35 (10), 2034-8
PubMed 2551540

Kvalheim G, Fjeld JG, Pihl A, Funderud S, Ugelstad J, Fodstad O, Nustad K (1989)
Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies
Bone Marrow Transplant, 4 (5), 567-74
PubMed 2790334

Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP, Bast RC (1989)
Elimination of malignant clonogenic breast cancer cells from human bone marrow
Cancer Res, 49 (16), 4659-64
PubMed 2663144

Fjeld JG, Benestad HB, Stigbrand T, Nustad K (1988)
In vivo evaluation of radiolabelled antibodies with antigen-coated polymer particles in diffusion chambers
J Immunol Methods, 109 (1), 1-7
DOI 10.1016/0022-1759(88)90435-8, PubMed 3356905

UGELSTAD J, BERGE A, ELLINGSEN T, AUNE O, KILAAS L, NILSEN TN, SCHMID R, STENSTAD P, FUNDERUD S, KVALHEIM G, NUSTAD K, LEA T, VARTDAL F, DANIELSEN H (1988)
MONOSIZED MAGNETIC PARTICLES AND THEIR USE IN SELECTIVE CELL-SEPARATION
MAKROMOL CHEM-M SYMP, 17, 177-211
DOI 10.1002/masy.19880170113

Paus E, Fosså A, Fosså SD, Nustad K (1988)
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma
J Urol, 139 (3), 542-4
DOI 10.1016/s0022-5347(17)42515-8, PubMed 2449547

Kvalheim G, Sørensen O, Fodstad O, Funderud S, Kiesel S, Dörken B, Nustad K, Jakobsen E, Ugelstad J, Pihl A (1988)
Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use
Bone Marrow Transplant, 3 (1), 31-41
PubMed 3048468

KVALHEIM G, FODSTAD O, FUNDERUD S, KIESEL S, DORKEN B, NUSTAD K, PIHL A (1988)
IMMUNOMAGNETIC PURGING OF BETA-LYMPHOMA CELLS FROM BONE-MARROW
Bone Marrow Transplant., 3 1, 97

Paus E, Fosså SD, Risberg T, Nustad K (1987)
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma
Br J Urol, 59 (6), 572-7
DOI 10.1111/j.1464-410x.1987.tb04880.x, PubMed 3690188

Johansen L, Berg T, Bergundhaugen H, Nustad K, Scicli AG, Carretero OA (1987)
Excess antibody immunoassay for the measurement of tonin in rat tissues and plasma
J Immunol Methods, 98 (2), 257-65
DOI 10.1016/0022-1759(87)90013-5, PubMed 3033082

Vergote I, Onsrud M, Nustad K (1987)
Placental alkaline phosphatase as a tumor marker in ovarian cancer
Obstet Gynecol, 69 (2), 228-32
PubMed 3808507

Kvalheim G, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S (1987)
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
Cancer Res, 47 (3), 846-51
PubMed 3492268

NUSTAD K, MICHAELSEN TE, KIERULF B, FJELD JG, KVALHEIM G, PIHL A, UGELSTAD J, FUNDERUD S (1987)
ANTIGEN-BINDING PROPERTIES OF ANTIBODIES COATED ON MAGNETIC POLYMER BEADS
Bone Marrow Transplant., 2 2, 81-83

Danielsen H, Funderud S, Nustad K, Reith A, Ugelstad J (1986)
The interaction between cell-surface antigens and antibodies bound to monodisperse polymer particles in normal and malignant cells
Scand J Immunol, 24 (2), 179-87
DOI 10.1111/j.1365-3083.1986.tb02084.x, PubMed 3749814

Berg T, Johansen L, Nustad K (1985)
Enzymatic activity of rat submandibular gland kallikrein released into blood
Am J Physiol, 249 (6 Pt 2), H1134-42
DOI 10.1152/ajpheart.1985.249.6.H1134, PubMed 3852648

BERG T, JOHANSEN L, NUSTAD K (1985)
ENZYMATIC-ACTIVITY OF RAT SUBMANDIBULAR-GLAND KALLIKREIN RELEASED INTO BLOOD
Am. J. Physiol., 249 (6), 1134-1142

UGELSTAD J, MFUTAKAMBA HR, MORK PC, ELLINGSEN T, BERGE A, SCHMID R, HOLM L, JORGEDAL A, HANSEN FK, NUSTAD K (1985)
PREPARATION AND APPLICATION OF MONODISPERSE POLYMER PARTICLES
J POLYM SCI POL SYM (72), 225-240

Millán JL, Nustad K, Nørgaard-Pedersen B (1985)
Highly sensitive solid-phase immunoenzymometric assay for placental and placental-like alkaline phosphatases with a monoclonal antibody and monodisperse polymer particles
Clin Chem, 31 (1), 54-9
PubMed 3880682

Johansen L, Nustad K, Berg T, Pierce JV (1984)
Excess antibody immunoassay for rat glandular kallikrein. Measurement of kallikrein complexed with inhibitors and in plasma
J Immunol Methods, 69 (2), 253-66
DOI 10.1016/0022-1759(84)90323-5, PubMed 6201559

NUSTAD K, CLOSS O, UGELSTAD J (1984)
MOUSE MONOCLONAL ANTI RABBIT IGG COUPLED TO MONODISPERSE POLYMER PARTICLES - COMPARISON WITH POLYCLONAL ANTIBODIES IN RADIOIMMUNOASSAY FOR THYROID-HORMONES
Dev. Biols, 57, 321-324

Nustad K, Johansen L, Ugelstad J, Ellingsen T, Berge A (1984)
Hydrophilic monodisperse particles as solid-phase material in immunoassays: comparison of shell-and-core particles with compact particles
Eur Surg Res, 16 Suppl 2, 80-7
DOI 10.1159/000128626, PubMed 6562963

Nustad K, Monrad-Hansen HP, Paus E, Millán JL, Nørgaard-Pedersen B (1984)
Evaluation of a new, sensitive radioimmunoassay for placental alkaline phosphatase in pre- and post-operative sera from the Danish testicular cancer material
Prog Clin Biol Res, 166, 337-48
PubMed 6504939

Nustad K, Closs O, Ugelstad J (1984)
Mouse monoclonal anti rabbit IgG coupled to monodisperse polymer particles. Comparison with polyclonal antibodies in radioimmunoassay for thyroid hormones
Dev Biol Stand, 57, 321-4
PubMed 6526143

Johansen L, Orstavik TB, Nustad K, Holck M (1983)
Excess antibody immunoassays for rat glandular kallikreins. Measurement of kallikrein from different organs in the presence of cross-reacting antigens
J Immunol Methods, 59 (3), 315-26
DOI 10.1016/0022-1759(83)90192-8, PubMed 6343492

Johansen L, Nustad K, Orstavik TB, Ugelstad J, Berge A, Ellingsen T (1983)
Excess antibody immunoassay for rat glandular kallikrein. Monosized polymer particles as the preferred solid phase material
J Immunol Methods, 59 (2), 255-64
DOI 10.1016/0022-1759(83)90038-8, PubMed 6341471

Skinningsrud A, Nustad K (1982)
Prostatic acid phosphatase, purification and iodination using Iodogen
Clin Chim Acta, 120 (1), 29-40
DOI 10.1016/0009-8981(82)90074-2, PubMed 7067137

Matsas R, Proud D, Nustad K, Bailey GS (1981)
Rapid purification of a prekallikrein from rat pancreas
Anal Biochem, 113 (2), 264-70
DOI 10.1016/0003-2697(81)90076-2, PubMed 6912775

Gautvik KM, Johansen L, Svindahl K, Nustad K, Orstavik TB (1980)
Isolation of rat submandibula kallikreins by using immunoadsorption chromatography
Biochem J, 189 (1), 153-9
DOI 10.1042/bj1890153, PubMed 7006596

Orstavik TB, Gautvik KM, Nustad K (1980)
Intraglandular transport of 125I-glandular kallikrein in the rat submandibular salivary gland
Acta Physiol Scand, 109 (3), 315-23
DOI 10.1111/j.1748-1716.1980.tb06602.x, PubMed 6905637

Orstavik TB, Brandtzaeg P, Nustad K, Pierce JV (1980)
Immunohistochemical localization of kallikrein in human pancreas and salivary glands
J Histochem Cytochem, 28 (6), 557-62
DOI 10.1177/28.6.6156199, PubMed 6156199

Orstavik TB, Nustad K, Brandtzaeg P (1979)
Origin of kallikrein in rat and human exocrine glands and kidney
Clin Sci (Lond), 57 Suppl 5, 239s-241s
DOI 10.1042/cs057239s, PubMed 396072

Orstavik TB, Nustad K, Gautvik KM (1979)
Localization of glandular kallikreins and secretion of kallikrein from the major salivary glands of the rat
Adv Exp Med Biol, 120A, 439-50
DOI 10.1007/978-1-4757-0926-1_40, PubMed 386736

Nustad K, Gautvik K, Orstavik T (1979)
Radioimmunoassay of rat submandibular gland kallikrein and the detection of immunoreactive antigen in blood
Adv Exp Med Biol, 120A, 225-34
DOI 10.1007/978-1-4757-0926-1_23, PubMed 495312

Orstavik TB, Nustad K, Brandtzaeg P (1977)
A biochemical and immunohistochemical study of kallikrein in normal and isoproterenol-stimulated rat salivary glands during postnatal development
Arch Oral Biol, 22 (8-9), 495-502
DOI 10.1016/0003-9969(77)90043-7, PubMed 341865

Proud D, Bailey GS, Orstavik TB, Nustad K (1977)
The location of prekallikrein in the rat pancreas [proceedings]
Biochem Soc Trans, 5 (5), 1402-4
DOI 10.1042/bst0051402, PubMed 411695

Brandtzaeg P, Gautvik KM, Nustad K, Pierce JV (1976)
Rat submandibular gland kallikreins: purification and cellular localization
Br J Pharmacol, 56 (2), 155-67
DOI 10.1111/j.1476-5381.1976.tb07438.x, PubMed 1252668

Nustad K, Vaaje K, Pierce JV (1975)
Synthesis of kallikreins by rat kidney slices
Br J Pharmacol, 53 (2), 229-34
DOI 10.1111/j.1476-5381.1975.tb07353.x, PubMed 1148483

Orstavik TB, Brandtzaeg P, Nustad K, Halvorsen KM (1975)
Cellular localization of kallikreins in rat submandibular and sublingual salivary glands: immunofluorescence tracing related to histological characteristics
Acta Histochem, 54 (2), 183-92
PubMed 56116

BERGORSTAVIK T, BRANDTZAEG P, NUSTAD K, HALVORSEN KM (1975)
CELLULAR LOCALIZATION OF KALLIKREINS IN RAT SUBMANDIBULAR AND SUBLINGUAL SALIVARY-GLANDS - IMMUNOFLUORESCENCE TRACING RELATED TO HISTOLOGICAL CHARACTERISTICS
Acta Histochem., 54 (2), 183-&

Nustad K, Pierce JV (1974)
Purification of rat urinary kallikreins and their specific antibody
Biochemistry, 13 (11), 2312-9
DOI 10.1021/bi00708a012, PubMed 4208777

Gautvik KM, Nustad K, Vystyd J (1972)
Kininogenase activity in the stimulated submandibular salivary gland in cats
Acta Physiol Scand, 85 (4), 438-45
DOI 10.1111/j.1748-1716.1972.tb05277.x, PubMed 5074159

Nustad K (1972)
[The kinins and the inflammatory reaction]
Tidsskr Nor Laegeforen, 92 (11), 765-6
PubMed 5028895

Nustad K, Rubin I (1970)
Subcellular localization of renin and kininogenase in the rat kidney
Br J Pharmacol, 40 (2), 326-33
DOI 10.1111/j.1476-5381.1970.tb09925.x, PubMed 4321758

Nustad K (1970)
Localization of kininogenase in the rat kidney
Br J Pharmacol, 39 (1), 87-98
DOI 10.1111/j.1476-5381.1970.tb09558.x, PubMed 4315991

Nustad K (1970)
The relationship between kidney and urinary kininogenase
Br J Pharmacol, 39 (1), 73-86
DOI 10.1111/j.1476-5381.1970.tb09557.x, PubMed 5420147

Nustad K (1969)
Observations on the kininogenase activity of rat kidney and urine
Scand J Clin Lab Invest Suppl, 107, 97-8
PubMed 5375732

Ofstad E, Nustad K (1969)
The influence of major surgery on kinin-forming, kinin-destroying and alkaline phosphatase activities in urine
Scand J Clin Lab Invest Suppl, 107, 163-7
PubMed 5385119

Gautvik KM, Nustad K, Vystyd J (1969)
Kininogenase activity in the stimulated submandibular salivary gland in cat
Scand J Clin Lab Invest Suppl, 107, 101-2
PubMed 5375718

Amundsen E, Nustad K (1965)
Kinin-forming and destroying activities of cell homogenates
J Physiol, 179 (3), 479-88
DOI 10.1113/jphysiol.1965.sp007674, PubMed 5858625

AMUNDSEN E, NUSTAD K (1964)
KININ-FORMING AND DESTROYING ACTIVITIES OF SALIVA
Br J Pharmacol Chemother, 23 (3), 440-4
DOI 10.1111/j.1476-5381.1964.tb01600.x, PubMed 14256804

AMUNDSEN E, NUSTAD K (1964)
KINIRASE ACTIVITY OF HUMAN SALIVA
Nature, 201, 1226-7
DOI 10.1038/2011226a0, PubMed 14151380

AMUNDSEN E, NUSTAD K, WAALER B (1963)
A STABLE SUBSTRATE FOR THE ASSAY OF PLASMA KININ-FORMING ENZYMES
Br J Pharmacol Chemother, 21 (3), 500-8
DOI 10.1111/j.1476-5381.1963.tb02018.x, PubMed 14110750

Review articles

Lea T, Vartdal F, Nustad K, Funderud S, Berge A, Ellingsen T, Schmid R, Stenstad P, Ugelstad J (1988)
Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro
J Mol Recognit, 1 (1), 9-18
DOI 10.1002/jmr.300010104, PubMed 3078840

Nustad K, Orstavik TB, Gautvik KM, Pierce JV (1978)
Glandular kallikreins
Gen Pharmacol, 9 (1), 1-9
DOI 10.1016/0306-3623(78)90049-6, PubMed 346434

Other articles

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2012)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera (vol 49, pg 2001, 2011)
Clin. Chem. Lab. Med., 50 (2), 409
DOI 10.1515/cclm-2012-0038

Bjerner J, Børmer OP, Nustad K (2005)
The war on heterophilic antibody interference
Clin Chem, 51 (1), 9-11
DOI 10.1373/clinchem.2004.042994, PubMed 15613705

Rye PD, Nustad K, Stigbrand T (2003)
Tumor marker workshops
Tumour Biol, 24 (4), 165-71
DOI 10.1159/000074423, PubMed 14654709

Stigbrand T, Andrés C, Bellanger L, Bishr Omary M, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjödin A, Sundström B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J (1998)
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop
Tumour Biol, 19 (2), 132-52
DOI 10.1159/000029984, PubMed 9486565

Nustad K, Bast RC, Brien TJ, Nilsson O, Seguin P, Suresh MR, Saga T, Nozawa S, Børmer OP, de Bruijn HW, Nap M, Vitali A, Gadnell M, Clark J, Shigemasa K, Karlsson B, Kreutz FT, Jette D, Sakahara H, Endo K, Paus E, Warren D, Hammarström S, Kenemans P, Hilgers J (1996)
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine
Tumour Biol, 17 (4), 196-219
DOI 10.1159/000217982, PubMed 8685601

Nap M, Vitali A, Nustad K, Bast RC, O'Brien TJ, Nilsson O, Seguin P, Suresh MR, Børmer OP, Saga T, de Bruijn HW, Nozawa S, Kreutz FT, Jette D, Sakahara H, Gadnell M, Endo K, Barlow EH, Warren D, Paus E, Hammarström S, Kenemans P, Hilgers J (1996)
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop
Tumour Biol, 17 (6), 325-31
PubMed 8938947

Frengen J, Schmid R, Kierulf B, Nustad K, Paus E, Berge A, Lindmo T (1993)
Homogeneous immunofluorometric assays of alpha-fetoprotein with macroporous, monosized particles and flow cytometry
Clin Chem, 39 (10), 2174-81
PubMed 7691444

BORMER O, NUSTAD K, PAUS E (1987)
CLINICAL UTILITY OF TUMOR-MARKERS
Scand. J. Clin. Lab. Invest., 47 (3), 301-302

Orstavik TB, Brandtzaeg P, Nustad K, Pierce JV (1981)
Effects of different tissue processing methods on the immunohistochemical localization of kallikrein in the pancreas
J Histochem Cytochem, 29 (8), 985-8
DOI 10.1177/29.8.7024403, PubMed 7024403

Proud D, Bailey GS, Nustad K, Gautvik KM (1977)
The immunological similarity of rat glandular kallikreins
Biochem J, 167 (3), 835-8
DOI 10.1042/bj1670835, PubMed 414745

Orstabik TB, Nustad K, Brandtzaeg P, Pierce JV (1976)
Cellular origin of urinary kallikreins
J Histochem Cytochem, 24 (9), 1037-9
DOI 10.1177/24.9.965714, PubMed 965714

Books

Frengen J, Kierulf B, Schmid RB, Nustad K, Lindmo T (1994)
Demonstration and minimization of serum interference in flow cytometric two-site immunoassays
American Association of Clinical Chemistry, [Winston-Salem, N.C.], S. 420-425
BIBSYS 941140954

Frengen J, Kierulf B, Schmid RB, Nustad K, Lindmo T (1993)
Clinical evaluation of a flow cytometric particle-based immunometric assay for AFP in serum
[Wiley-Liss], [New York], Bl. 74.
BIBSYS 931704650

Frengen J, Kierulf B, Schmid RB, Nustad K, Lindmo T, Berge A (1993)
Homogeneous immunofluorometric assays of α-fetoprotein with macroporous monosized particles and flow cytometry
American Association of Clinical Chemistry, [Winston-Salem, N.C.], S. 2174-2181
BIBSYS 941140873

Nustad K (1974)
The relationship between urinary and kidney kallikreins in the rat
Oslo, 1 b. (Flere pag.)
BIBSYS 000871605

0.16s